Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Franklin Genomic Advancements Fund N (acc) EUR Fonds 113722568 / LU2387457729

6.26 EUR
0.02 EUR
0.32 %
18.2.2025
NAV

Nettoinventarwert (NAV)

6.26 EUR 0.02 EUR 0.32 %
Vortag 6.24 EUR Datum 18.02.2025

Franklin Genomic Advancements Fund N (acc) EUR Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares The Sandbox ETP CH1177361008 134.26%
21Shares Ripple XRP ETP CH0454664043 116.28%
21Shares Decentraland ETP USD Accumulation CH1161102699 76.29%
21Shares Cosmos ETP CH1145930991 70.35%
21Shares Sui Staking ETP CH1360612159 -17.95%
21Shares Immutable ETP CH1360612142 -32.85%
21Shares Injective Staking ETP CH1360612134 -36.08%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 349.74%
21Shares Sui Staking ETP CH1360612159 248.07%
21Shares Stellar ETP CH1109575535 237.14%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Cardano ETP CH1102728750 130.18%
21Shares Aave ETP CH1135202120 127.09%
21Shares Injective Staking ETP CH1360612134 -22.16%
21Shares Immutable ETP CH1360612142 -29.31%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 342.21%
21Shares Stellar ETP CH1109575535 171.46%
21Shares Aave ETP CH1135202120 165.26%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 136.93%
21Shares Bitcoin Core ETP CH1199067674 83.67%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 657.12%
21Shares Ripple XRP ETP CH0454664043 523.03%
21Shares Bitcoin Core ETP CH1199067674 294.24%
21Shares Bitcoin ETP CH0454664001 284.31%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 275.41%

Fundamentaldaten

Valor 113722568
ISIN LU2387457729
Emittent Franklin Templeton International Services
Aufgelegt in Luxembourg
Auflagedatum 15.10.2021
Kategorie Branchen: Gesundheitswesen
Währung EUR
Volumen 3’200’331.23
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 30.06.
Berichtsstand 18.02.2025

Anlagepolitik

So investiert der Franklin Genomic Advancements Fund N (acc) EUR Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.

ETP Performance: Franklin Genomic Advancements Fund N (acc) EUR Fonds

Performance 1 Jahr
-2.95
Performance 2 Jahre
-4.72
Performance 3 Jahre
-15.18
Performance 5 Jahre -
Performance 10 Jahre -